ARCHIVES

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

This article is from The Cancer Letter archive.

Vol. 02 No. 41 | October 8, 1976

Download PDF Visit The Full Archive

Related Articles

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007

NCI to Recompete contracts for Frederick

December 4, 1992

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001